$6.470
0.000 (0.00%)終値時点
価格予想
アプリで開くと、より長期の予想を確認できます。
Sinovac Biotech Ltd 株は買うべき？
Sinovac Biotech Ltd is currently not a strong buy due to its negative financial metrics, including a forward P/E ratio of 357.14, indicating high valuation concerns. While the company has declared a special cash dividend of $55 per share, which could enhance shareholder confidence, the overall financial performance shows significant risks, particularly with a negative price-to-earnings ratio of -1.87. The main risk is the high forward P/E ratio, suggesting that the stock may be overvalued at its current price.
SVA の株価は Friday に $6.47 で引け、その前に上昇 0.00%
Sinovac Biotech Ltd (SVA) last closed at $6.47, gaining +0.00%. These facts feed the 1-day and 1-week SVA price prediction above.
予想の要因
Sinovac Biotech Ltd（SVA）の予想は、類似したチャートパターン・季節性・移動平均を組み合わせています。
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
SVA の季節性分析
Historically the probability of a positive September return for SVA is 0.00%. January offers the highest probability of a positive month at 0.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。